CNBC February 14, 2024
Annika Kim Constantino

Key Points

– The Federal Trade Commission said it is examining the role drug wholesalers and companies that purchase medicines for U.S. health-care providers play in shortages of generic drugs.

– The move follows an unprecedented shortfall of crucial medicine over the last year, which has forced hospitals to ration drugs ranging from injectable cancer therapies to pain treatments.

– In a joint request for information, the FTC and the Department of Health and Human Services are seeking public comment on the contracting practices, market concentration, and compensation of two types of middlemen: group purchasing organizations and drug wholesalers.

The Federal Trade Commission on Wednesday said it is examining the role that drug wholesalers and companies that purchase medicines for...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, Govt Agencies, Pharma, Pharma / Biotech, Supply Chain, Technology
Amazon Business helps evolve the traditional supply chain
HHS floats hospital pay incentives to strengthen drug supply
AstraZeneca plans independent drug supply chains for US and China, CEO says
Vitality in the Supply Chain: The Limitless Potential of ATMPs
Red Sea Shipping Disruptions Don’t Have Pharma Companies Seeing Red Just Yet

Share This Article